ISOPP CAPhO Symposium 2025

Teresa Isabel Dias is a pharmacist with over 30 years of experience in community pharmacy and drug information, a Menopause Society Certified Practitioner (MSCP, formerly NCMP), and a woman’s health advocate.

Specializing in midlife hormonal changes, Teresa offers guidance on managing physical, emotional, and mental challenges, helping women to regain balance and vibrancy in their lives, both professionally and personally.

Her educational programs have been deployed to prestigious institutions and corporations including the Ontario Public Service, RBC, Maple Leaf Foods, CAA, OMAFRA, Open Societies Foundation, University of Toronto, Waterloo, Fraser Valley, Toronto Metropolitan University, and others.

Beyond the corporate sphere, Teresa has contributed expert talks to several pharmacy associations and articles to the Pharmacy Practice + Business magazine.
 

Axel Tosikyan has been a hematologist-oncologist at Hôpital du Sacré-Cœur de Montréal since 2006. He is also an assistant professor at the Université de Montréal. Additionally, he has a part-time practice in Abitibi. Dr. Tosikyan graduated from McGill University in 2006 with certifications in both hematology and oncology. He subsequently obtained a Master's in Public Health from the Harvard School of Public Health. He has a diverse practice and participates as the principal investigator in numerous research protocols in the fields of hematology and oncology.

Dr. Christine Peragine is the Lead Pharmacist for Sunnybrook’s Oral Anticancer Medication (OAM) Program at the Odette Cancer Centre, Toronto, Ontario, Canada. Christine graduated from the University of Toronto combined BScPhm-PharmD program in 2015 and started her PhD training and Antimicrobial Stewardship-Infectious Disease Pharmacy Fellowship in the same year. She has worked in Ambulatory Oncology since 2018 and is passionate about advancing pharmacy practice, research, and education. Over the course of her career, Dr. Peragine has spearheaded over 25 practice-based research initiatives, published over 30 unique abstracts, and presented at over 15 academic conferences. She has received over $110,000 CAD in grant funding and was the recipient of the 2022 Sunnybrook Practice-Based Research and Innovation Award of Inquiry. Her commitment to teaching is demonstrated by the number of students and trainees she has precepted (>30), and the creation and launch of clinical and research co-op opportunities with the OAM Team in Fall 2022.

Glenn Myers is a pharmacist with a focus in outpatient medical oncology at the Dr. Sheldon H Rubin Oncology Clinic in Moncton, New Brunswick. Glenn completed a BSc (Pharmacy) at Dalhousie University in 2011 and subsequently went on to complete his hospital residency at the Saint John Regional Hospital in New Brunswick. Glenn has been practicing in ambulatory oncology for over 12 years and focuses on clinical assessment and management of chemotherapy, oral anti-cancer, and immune related adverse effects in patients with cancer. His other professional interests include teaching and mentoring various levels of pharmacy learners, providing practical education to healthcare professionals, working with retail pharmacies to improve oncology patient care in the community, and performing oncology pharmacy practice-based research to advance the scope of oncology pharmacy.

Dr. Maryam Soleimani is a Genitourinary Medical Oncologist at BC Cancer, Vancouver Cancer Centre and a clinical assistant professor at the University of British Columbia.

She has a special interest in immuno-oncology, renal cell carcinoma, and cancer care delivery. She has received multiple recognitions for her academic work. She is actively involved in both clinical and translational research, and in oncology clinical trials, with a successful track record of publications in peer-reviewed journals. Dr. Soleimani is an expert in TKI dose individualization to accommodate TKI toxicity while maintaining adherence.

I was born and raised in BC and worked in the construction trades before studying Civil Engineering at UBC. I have just retired from my career with a large construction company that entailed managing design and construction for large infrastructure projects, including the Port Mann Bridge and Coquihalla Highway 5 Bridge rebuilds. I am married and have two adult children who live close by. I enjoy cycling, hiking, and exploring.

My cancer diagnosis a year ago was a shock. I went in for an x-ray for what I thought was a dislocated shoulder and came out with a diagnosis of stage 4 renal carcinoma. The shoulder injury was actually a break of the upper left arm at the location of a large tumour. There were also tumours on two vertebrae. Last year was a challenge, with the removal of the right kidney followed by radiation of the spinal tumours, a shoulder replacement, discovery of additional tumours, and then the start of immunotherapy. I am very grateful for the excellent treatment I have received.

A dedicated regulated technician contributing to the advancement of automated systems in oncology compounding.

Known for his work in enhancing patient safety and efficiency in oncology compounding.

An expert in oncology pharmacy with extensive experience in optimizing automation
technologies.

leading initiatives in automation to improve chemotherapy preparation.

A senior pharmacist with a focus on optimizing pharmacy workflows.

Specializes in training and qualification of pharmacy staff in automated systems.

Former Head of pharmacy, a leading pharmacist in oncology reputed for his innovative approaches to patient
care.

Expert in optimizing patient wait times and enhancing the efficiency of chemotherapy
preparation.

Melanie Dorey is a registered pharmacy technician and has worked in the compounding industry since 2006. She graduated from a 2-year Pharmacy Technician program in 2006 and at the Children’s Hospital of Eastern Ontario (CHEO) where she acquired a passion for sterile and nonsterile compounding. While attending the Sterile Compounding Boot Camp in Denver, Colorado in 2007, Melanie met several key industry experts who ignited her passion for sterile and nonsterile compounding. In 2014, she joined the team at CriticalPoint and Kastango Consulting Group where she continued to hone her skills while developing eLearning, standard operating procedures, as well as in person and virtual lectures. She also traveled to client locations to perform competency assessment and customized training. Melanie has served on a variety of committees with NAPRA and the Ontario College of Pharmacy. Melanie is the owner of Critical Compounding Resources which offers services to compounding operations across North America. 

Mary Nazzal, a PharmD, Registered Pharmacist, is the Co-owner and Director of Field Operations for Critical Compounding Resources LLC (CCR). She received her PharmD degree from Butler University of Indianapolis and has completed the Nuclear Pharmacy Certificate Program at Purdue University. Mary received her Compounded Sterile Preparations Certification from the Board of Pharmacy Specialties in the fall of 2019 as a member of its inaugural class.

She has over 18 years of progressive and diverse hospital pharmacist experience, including administrative, inpatient pharmacy, de-centralized pharmacy, and operating room, focusing on sterile compounding. Before co-owning CCR LLC, Mary was the Director of Field Operations for Kastango Consulting Group, a TRC Healthcare Company, where she directed the day-to-day consulting operations. Before that, Mary established and led sterile compounding services, including pharmacy-related policy/procedure/SOP development, technology setup and implementation, training development, and execution for Cleveland Clinic, Abu Dhabi, in the United Arab Emirates. She currently performs gap analysis, facility design development, and review of construction documents for clients to ensure regulatory compliance and provide best practice recommendations regarding compounding. In addition, she is involved in product development for CCR. She is also a member of the American Society of Health-System Pharmacists (ASHP), Indiana Pharmacists Association, Controlled Environment Testing Association (CETA) and the Parenteral Drug Association (PDA). She recently became a member of the ASHP Section of Inpatient Care Practitioners Section Advisory Groups: Compounding Practice.

Mark, a seasoned professional with over 30 years of diverse experience.

With a background encompassing Department of Defense, Federal Government, and private sector Industrial Hygiene roles, Mark brings expertise in healthcare, Biosafety laboratory/research, and specialty evaluation and certification of controlled environments.

Previously, he served as the National Industrial Hygiene Program Manager for the Department of Veterans Affairs, overseeing Occupational Safety and Health and USP 797/800 policy development, implementation, and compliance across 175+ Medical Centers.

A retired U.S. Air Force Industrial Hygiene Bioenvironmental Engineering Professional, he holds certifications as a Certified Industrial Hygienist (CIH), and Controlled Environment Testing Association CNBT Registered Certification Professional for Sterile Compounding Facilities (RCCP-SCF).

Mark is dedicated to STEM education and training. During his tenure at the USAF School of Aerospace Medicine, he instructed new Air Force enlisted and officer Industrial Hygiene Bioenvironmental Engineering Airmen, teaching a comprehensive curriculum covering industrial hygiene principles, analytical chemistry, air monitoring techniques, and more. Mark is currently an Adjunct Instructor in the Certification of Sterile Compounding Facilities Course at the Eagleson Institute, Sanford, ME.

Scott Edwards is currently the Clinical Oncology Pharmacy Specialist at the Dr. H. Bliss Murphy Cancer Center in St. John’s, Newfoundland. He is also an assistant professor at the School of Pharmacy and the Discipline of Oncology, Faculty of Medicine, Memorial University of Newfoundland. He is active in clinical cancer research in the area of chemotherapy toxicities, supportive care and oral chemotherapy adherence. He graduated from Memorial University of Newfoundland with a B.Sc. (Neuroscience) in 1994 and a B.Sc (Pharmacy) in 1997. In 2005, he graduated with a Doctor of Pharmacy degree from the University of Washington. He completed a Master’s degree in Oncology from Newcastle University in 2015.

Michael LeBlanc is Director of Pharmacy Professional Practice for Horizon Health Network, New Brunswick. He is responsible for the development, evaluation and monitoring of clinical pharmacy services. He graduated from Memorial University of Newfoundland in 1998 and received his PharmD from Idaho State University in 2009. Michael has been an oncology pharmacist for 25 years with a focus on the prevention and management of cancer-treatment associated toxicities. He is active in practice-based research and providing support for patients receiving oral anticancer medications. Michael is a member of the CAPHO Research Committee, FCAPHO Task Force, ambulatory oncology cpKPI working group, and the CAPHO24 Planning Committee.

He is also active in the Canadian Society of Hospital Pharmacists where he gained fellowship status in 2015 and is the current chair of the Board of Trustees for the CSHP Research and Education Foundation.

Dr. Christine Peragine is the Lead Pharmacist for Sunnybrook’s Oral Anticancer Medication (OAM) Program at the Odette Cancer Centre, Toronto, Ontario, Canada. Christine graduated from the University of Toronto combined BScPhm-PharmD program in 2015 and started her PhD training and Antimicrobial Stewardship-Infectious Disease Pharmacy Fellowship in the same year. She has worked in Ambulatory Oncology since 2018 and is passionate about advancing pharmacy practice, research, and education. Over the course of her career, Dr. Peragine has spearheaded over 25 practice-based research initiatives, published over 30 unique abstracts, and presented at over 15 academic conferences. She has received over $110,000 CAD in grant funding and was the recipient of the 2022 Sunnybrook Practice-Based Research and Innovation Award of Inquiry. Her commitment to teaching is demonstrated by the number of students and trainees she has precepted (>30), and the creation and launch of clinical and research co-op opportunities with the OAM Team in Fall 2022.

Melissa received her PharmD from University of the Sciences in Philadelphia in 2011 and went on to complete an Ambulatory Pharmacy Practice Residency at Sunnybrook Health Sciences Centre in 2012. Shortly after, she joined the ambulatory pharmacy team at Princess Margaret Cancer Centre where she has been practicing for the past 13 years. She has participated in a variety of educational roles and quality improvement projects. She was part of the pilot project exploring the role of a pharmacist in an interdisciplinary outpatient complex malignant hematology clinic and most recently completing a secondment with Investigational Pharmacy Services.

Marc Geirnaert graduated with his Bachelor of Sciences in Pharmacy from the University of Manitoba in 2002.  He has been working in oncology at CancerCare Manitoba since January 2003 and has worked in lymphoproliferative disorders, genitourinary and central nervous system clinics until 2014.  In 2014, Marc started in his role as Director of the Provincial Oncology Drug Program.  Marc is a Board Certified Oncology Pharmacist and has completed his Masters in Health Pharmacoeconomics.  His interests lies in allergy and immunology, novel methods of administration and implementation of new and novel therapies.

Scott Edwards is currently the Clinical Oncology Pharmacy Specialist at the Dr. H. Bliss Murphy Cancer Center in St. John’s, Newfoundland. He is also an assistant professor at the School of Pharmacy and the Discipline of Oncology, Faculty of Medicine, Memorial University of Newfoundland. He is active in clinical cancer research in the area of chemotherapy toxicities, supportive care and oral chemotherapy adherence. He graduated from Memorial University of Newfoundland with a B.Sc. (Neuroscience) in 1994 and a B.Sc (Pharmacy) in 1997. In 2005, he graduated with a Doctor of Pharmacy degree from the University of Washington. He completed a Master’s degree in Oncology from Newcastle University in 2015.

Dr. Mita Manna is a dual trained Hematologist and Medical Oncologist. Currently, she is a Medical Oncologist at the Saskatoon Cancer Centre, Saskatchewan Cancer Agency in Saskatoon as well as Associate Professor within the Department of Oncology, University of Saskatchewan. Dr. Manna’s main areas of clinical focus include breast and thoracic malignancies. She is the Provincial Disease Site Group Chair for Breast Malignancies and is the Multidisciplinary Tumor Board Chair for Breast Malignancies. She is a nucleus member of the REAL Canadian Breast Cancer Alliance, and site representative for the Canadian Cancer Trials Group. Other areas of interest includes medical education, patient advocacy, and patient education.

Glenn is a clinical resource pharmacist with a patient care focus in outpatient medical oncology at the Dr. Sheldon H Rubin Oncology Clinic in Moncton, New Brunswick. Glenn completed a BSc (Pharmacy) at Dalhousie University in 2011 and subsequently went on to complete his hospital residency at the Saint John Regional Hospital in New Brunswick. Glenn has been practicing in ambulatory oncology for over 12 years and focuses on clinical assessment and management of chemotherapy, oral anti-cancer, and immune related adverse effects in patients with cancer. Glenn also enjoys providing practical education to healthcare professionals in oncology and non-oncology settings.

Dr. Aalok Kumar completed medical school at the University of Toronto, Internal Medicine training at McMaster University and Medical Oncology training along with a fellowship in medical gyne-oncology at BC Cancer/UBC. He has also completed his Masters of Health Sciences at UBC. He currently is the Department Head of Medical Oncology at BC Cancer Surrey, works as a medical oncologist treating patients with breast and gynecological cancers, actively involved in clinical trials, medical education and health outcomes research.  ​He is also the Provincial Systemic Chair for Gynecologic Oncology in British Columbia and the Director for Career Planning for the Faculty of Medicine at UBC.

Catherine Arnatt is an integrated clinical pharmacist at the Anchorage Native Primary Care Center with the Southcentral Foundation (SCF)/Alaska Native Medical Center (ANMC) and an officer with the US Public Health Service working within the Indian Health Service. CDR Arnatt has worked for the last 12 years with the Southcentral Foundation, a tribally owned health care organization serving nearly 70,000 Alaska Native and American Indian people in South Central Alaska. 

Catherine Arnatt received her Doctorate of Pharmacy from Virginia Commonwealth University’s Medical College of Virginia. She holds a Master of Science in Human Services Management, with an emphasis in Applied Behavior Analysis, and a Bachelor’s degree in Psychology with a minor in Sociology. Dr Arnatt is a Fellow of the Alaska Pharmacists Association and is Board Certified in Psychiatric Pharmacy. She acts as a Subject matter expert on Medication Assisted Treatment (MAT) and chronic pain management. She has held positions with behavioral health and special education programs serving children and adults with developmental disabilities and neuropsychiatric conditions, non-profit long-term care, outpatient clinics, and public-school settings. Cathy Arnatt enjoys travel and family time, advocating for underserved populations, and learning new things.

Adrienne Tveit is a Board-Certified Pharmacotherapy Specialist and currently works as an integrated clinical pharmacist at the Anchorage Native Primary Care Center with Southcentral foundation on the Alaska Native Medical Center campus in Anchorage, Alaska.  Alaska Native Medical Center is jointly owned and operated by Alaska Native Tribal Health Consortium and Southcentral Foundation, a tribally owned health care organization serving nearly 70,000 Alaska Native and American Indian people in Southcentral Alaska. Dr. Tveit has over 17 year’s experience at Southcentral Foundation.

Adrienne Tveit is Alaska Native of Tlingit Indian descent. Her family originated from Southeast Alaska, and she was born and raised in Kodiak, Alaska. Dr. Tveit attended the University of Alaska Fairbanks to obtain her undergraduate degree in Health Studies with an emphasis in Psychology, she went on to Washington State University and obtained her Doctor of Pharmacy degree before moving to Anchorage, Alaska to complete a PGY1 Pharmacy residency at the Alaska Native Medical Center. At Southcentral Foundation, Dr. Tveit has an interest in Infectious disease, she is on the Antimicrobial Stewardship Committee and precepts Pharmacy residents for an Infectious disease learning experience. 

Dr. Kaitlyn Watson, an Australian registered pharmacist began her pharmacy career working in an Oncology Day Unit at Greenslopes Private Hospital, Australia. Dr Watson went on to become a globally recognized disaster pharmacy researcher, serving as the Founder & CEO of Disaster Pharmacy Solutions. She specializes in delivering disaster management and emergency preparedness training to the pharmacy workforce through interactive Table-Top Exercises. In 2022, Kaitlyn authored the foundational book 'Disaster and Emergency Pharmacy: A Guide to Preparation and Management' published by Routledge. 

Dr. Watson is an Assistant Professor at the University of Alberta's Faculty of Pharmacy and Pharmaceutical Sciences, focusing on social and public health pharmacy. Dr. Watson earned her PhD in Pharmacy Practice and Disaster Management from Queensland University of Technology, Australia. Her doctoral research focused on a comprehensive exploration of pharmacists' roles and responsibilities in both natural and anthropogenic disasters and emergencies. Additionally, with expertise gained through two postdoctoral fellowships in clinical trial management and implementation science, Dr. Watson is dedicated to sustainable evidence-based change in the public health and primary care sectors. 

Professor Lita Chew, a pharmacist with over 30 years of oncology pharmacy experience, earned her pharmacy degree from the National University of Singapore and pursued advanced studies in clinical oncology at the University of Birmingham, UK. She also completed fellowship training in pharmacy practice at the University of Illinois Chicago. She has significantly influenced Singapore's allied health and pharmacy sectors, overseeing workforce, programs, and services development across SingHealth institutions. Prof. Chew played a key role in shaping the National Pharmacy Strategy, a 10-year transformation plan, and serves on the National Allied Health Strategy Steering Committee. A passionate leader, she focuses on workforce development to enhance care quality and safety.

PhD in Public Health, Specialist in Hospital Pharmacy in Logistics Operations Management. Works as a pharmacist in the Supply Division of the Brazilian National Cancer Institute (INCA), teaching postgraduate courses in Hospital Pharmacy, in INCA's Multiprofessional Residency Program in Oncology and in the Research Program in Collective Health and Cancer Control/INCA. President of the Brazilian Society of Oncology Pharmacists (SOBRAFO) for the 2025-2026 term. She has experience in Service Management, Supply Logistics and teaching in areas of Pharmaceutical Services and Public Procurement.

Lynne Nakashima received her BSc(Pharm) from the University of British Columbia, Canada and her PharmD from the University of North Carolina at Chapel Hill, USA. Lynne is a Fellow of both CAPhO and ISOPP and is currently the Chair of the ISOPP Grants and Awards Task Force as well as the CAPhO Fellow Task Force. She is currently the Senior Director, Provincial Pharmacy at BC Cancer in Canada where she is responsible for pharmacy professional practice leadership, provincial oncology medication management, support for the systemic therapy program and leadership for the Pharmacy Residency Program.

Shellyza Sajwani is a pharmacist who works within areas of oncology, climate change and global health as they relate to the pharmacy profession. Shellyza received her MPharm from Aston University in the UK, her PharmD from the University of Toronto, her Climate Change and Health certification from Yale University and her Global Health Intensive Delivery Certification from Harvard University . She is currently an adjunct professor at the University of Ottawa, and the national co-chair of the Canadian Association of Pharmacy for the Environment (CAPhE - pronounced Caa-fee ). She has also worked for many years as an oncology pharmacist at the Ottawa Hospital, with ten years of experience in a combination of outpatient and inpatient oncology, and also co-chairs the Ottawa Hospital Pharmacy Environmental Committee. 

Shellyza co-chaired the International Pharmaceutical Federation (FIP) policy committee, which created and passed the first ever international pharmacy climate change policy in 2023 which went to the over 100 country membership representing four million pharmacy professionals. She also represented the University of Ottawa and the CAPhE at the United Nations COP29 conference in 2024 . Shellyza is currently the co-founder of Climaceutics Health Solutions which focuses on building on tools and certifications  for pharmacies to reduce their emissions and improve their climate resilience. 

Shellyza also has experience working as a previous co-president of Pharmacists Without Borders Canada ; and has received CAPhO Merit awards for her work as an oncology pharmacy consultant in Gulu, Uganda in 2017 and 2018, as well as her later work advocating for cancer patients with various patient advocacy organizations during her own chemotherapy treatment and during her remission. 

Tina Crosbie is a clinical hematology pharmacist at The Ottawa Hospital. She works in the outpatient chemotherapy unit counseling patients with lymphoma, multiple myeloma, and acute and chronic leukemia.

For over 25 years, Tina has been part of the hematology multidisciplinary team at The Ottawa Hospital. She has written educational materials and has presented on topics in hematology and patient care.

For the last 6 years, Tina is also a hematology pharmacist at a community oncology-focused pharmacy called Extend Pharmacy. Here she empowers patients to manage their take home anti-cancer therapy.

Tina’s research interests are optimizing drug administration and patient education. Her volunteer work includes reviewing continuing education programs for the Canadian Council on Continuing Education in Pharmacy (CCCEP) and volunteering in various roles for CAPhO; the Canadian Association of Pharmacy in Oncology.

Tina received her Bachelor of Science in Pharmacy at Memorial University of Newfoundland and she completed an accredited residency in hospital pharmacy at The Ottawa Hospital.

Marc graduated in 2002 from the University of Manitoba with his Bachelor of Sciences in Pharmacy
degree. He has worked in oncology since January 2003 and since 2014, is the Director of the Provincial Oncology Drug
Program. Marc is a Board Certified Oncology Pharmacist and a Fellow of the Canadian Association of Pharmacy in
Oncology. Marc’s interests are implementation of new and novel cancer therapies, prevention and management of
hypersensitivity reactions and improving patient experience by adopting novel methods of drug delivery.

Andrea is a Haematology Specialist Pharmacist and Head of Patient Innovation and Care at Sanius Health. 

She is Founder and past Chair of the UK Myeloma Society Pharmacist Group, and a committee member on the British Oncology Pharmacy Association’s Research and AI Specialist interest groups. 

Andrea is passionate about innovation for patient benefit.  After co-creating an award-winning smartphone application to support patients with CML, she became an NHS Clinical Entrepreneur with NHS England and NHS Improvement’s Innovation, Research and Life Sciences group. 

Areas of specialist interest include medication adherence, dosing in obesity and use of technology to improve patient outcomes. 

Data-driven healthcare improvement is at the heart of Shirley Yeung's work as Provincial Pharmacy Information Systems Coordinator at BC Cancer. She ensures safe and effective pharmacy services by overseeing the selection, implementation, and maintenance of pharmacy computer systems and managing drug inventory and contracting. With a background in pharmaceutical sciences (UBC, 2009), a hospital pharmacy residency, and a Master's in Public Health (Health Economics) from the London School of Hygiene and Tropical Medicine (2014), Shirley brings a strong analytical lens to her role. In her free time, she enjoys swimming.

Abdelali Ouasrhir, is a pharmacist, researcher, and healthcare leader. He holds a PhD in Risk Management and an Executive MBA, bringing expertise in patient safety and healthcare innovation. He is the Head of the Clinical Research Department at the University Hospital of Oujda, Morocco, President of the Moroccan Association of Research and Training in Oncology Pharmacy, and Founder of a startup HealthBridgeTraining.com. He also coordinates the University Diploma in Oncology Pharmacy and has authored multiple publications, including the Practical Guide of Chemotherapy. Passionate about leadership and transformation in healthcare, he focuses on empowering professionals and integrating research into practice to drive innovation.

Katie Lacaria is a clinical pharmacy educator in leukemia and bone marrow transplantation at Vancouver General Hospital.  She completed a Hospital Pharmacy Residency Program from the University of British Columbia (UBC). She is a Clinical Instructor at UBC and a Clinical Consultant for Pharmacist’s Letter Canada.  Her areas of expertise and research interests include immunosuppressive pharmacotherapy, transplant-related infections, and drug allergies.

Netty has over 20 years’ experience as a specialist oncology pharmacist working in both government and private organisations within the UK. She is currently Principal Pharmacist – Operations, for Genesis Care UK. Netty is currently President of The International Society of Oncology Pharmacy Practitioners (ISOPP) and co-chair of the UK SACT Board. Netty has previously held various leadership positions within the British Oncology Pharmacy Association (BOPA) and has independently led several National and International Projects. Netty was announced a Fellow of the Royal Pharmaceutical Society in 2022 and a Fellow of BOPA in 2023. 

Netty is passionate about improving cancer care globally and improving safety for patients and staff through the use of digital media. Netty also has a keen interest in education and training and uses her strengths to support all pharmacy staff in all sectors and countries to improve access to learning globally.

Evelyn Handel, PharmD, BCPS, BCOP is Senior Director of Drugs & Biologics Programs at the National Comprehensive Cancer Network in Philadelphia, USA. In this role she collaborates with a multidisciplinary team and is responsible for strategic leadership and management of the NCCN Drugs & Biologics Compendium and the NCCN Chemotherapy Order Templates, which are derivative products of the NCCN Clinical Practice Guidelines in Oncology. Prior to joining NCCN, Evelyn was an oncology clinical pharmacy specialist in various direct patient care roles.

Evelyn is an active member of the International Society of Oncology Pharmacy Practitioners (ISOPP) as well as the Hematology/Oncology Pharmacy Association (HOPA). She has served in multiple volunteer leadership positions including Chair of the HOPA Patient Education Committee, as well as on the ISOPP Secretariat in various roles since 2015 including her current term as immediate Past President and Governance Committee Chair.

Marissa has two decades' worth of experience as a cancer pharmacist in both Australia and the United Kingdom. Marissa completed her PhD on the development, implementation and evaluation of a cancer pharmacy telehealth service. Her other published collaborative work includes the Clinical Oncology Society of Australia (COSA) Position Statement 2022 update on the safe handling of monoclonal antibodies in healthcare settings, medication safety related articles, and shared-care models. Marissa is currently supervising MPhil, MNP, and BPharm Majors students. She is Chair of the COSA Cancer Pharmacists Group and a member of the Executive Committee of the COSA Global Oncology Group and works in the Pharmacy Department at Princess Alexandra Hospital, Brisbane, as Acting Consultant Pharmacist in the Cancer Pharmacy team.

Irene holds a master’s degree in clinical pharmacy with specialization in oncology pharmacy from the University of Nairobi and has over 20 years’ experience as a specialist pharmacist, serving in national, regional and international expert advisory and technical working groups. She is an active member of several professional associations and has served on the ISOPP Board since 2020. Irene is an adjunct faculty at the University of Nairobi and Kabarak University, providing research and clinical practice supervision to undergraduate and postgraduate pharmacy students.

Long time CAPhO and CAPhO Conference organizing and sponsorship committee member. Member of ISOPP, and founding member of local Toronto oncology pharmacists’ group, OPTRA. Oncology pharmacy education is so important to what we do every day; it helps to inspire new and seasoned practitioners to make a difference for their patients.

Glenn is a clinical resource pharmacist with a patient care focus in outpatient medical oncology at the Dr. Sheldon H Rubin Oncology Clinic in Moncton, New Brunswick. Glenn completed a BSc (Pharmacy) at Dalhousie University in 2011 and subsequently went on to complete his hospital residency at the Saint John Regional Hospital in New Brunswick. Glenn has been practicing in ambulatory oncology for over 12 years and focuses on clinical assessment and management of chemotherapy, oral anti-cancer, and immune related adverse effects in patients with cancer. Glenn also enjoys providing practical education to healthcare professionals in oncology and non-oncology settings.

Kim is a Clinical Oncology Pharmacist with a focus on patient-centered, collaborative, team-based care at BC Cancer in Vancouver, British Columbia. She holds a Bachelor of Science in Pharmacy degree from the University of British Columbia, a Doctor of Pharmacy degree from the University of Toronto, and an Executive Certificate in Healthcare Leadership from the Rotman School of Management at the University of Toronto.

A lifelong learner, Kim is currently preparing to become a Board-Certified Oncology Pharmacist. Her clinical expertise and areas of interest include managing immunotherapy toxicities, as well as addressing treatment complications and survivorship challenges in stem cell transplant patients. Kim’s current research project focuses on interventions to reduce IV chemotherapy wastage and its economic and environmental impact.

Kim is actively involved in several pharmacy, oncology, and hematology organizations both in Canada and internationally. She has been a long-time member of CAPhO’s Education Committee and currently serves as the Team Lead of ISOPP’s Standards Task Force. Kim is passionate about clinical research, education, and volunteerism in the fields of pharmacy, oncology, and hematology.

Stephen F. Eckel is the Associate Dean for Global Engagement at the UNC Eshelman School of Pharmacy. He is also an associate professor in the Division of Practice Advancement and Clinical Education (PACE).

Afomia Gebre graduated from Dalhousie’s College of Pharmacy is 2020 and shortly after completed a hospital residency through the Nova Scotia Health Authority. After completing a residency, she went on to work as a hospital pharmacist at the Qikiqtani General Hospital in Iqaluit, Nunavut. Now, she currently works as a clinical pharmacist at the Children's Hospital Eastern Ontario (CHEO). Outside of Pharmacy, Afomia is mainly involved in working with and advocating for members of equity seeking groups.

Jurga McLean is an experienced hospital pharmacist and a Pre-Doctoral Research Fellow currently working at the Royal Marsden Hospital, UK. Her research area of interest lies within providing equitable cancer care to breast cancer patients who are receiving oral SACT. Jurga is an active member of BOPA research subcommittee and a Co-Chair of EDI subcommittee.  Jurga has recently published her “Scoping review identifying interventions that have been tested to optimise the experience of people from ethnic minority groups receiving systemic anti-cancer therapy (SACT)” and is continuing to work towards building her research proposal for further PhD studies. 

Jennifer graduated from the University of Alberta in 2000, obtaining her Board Certification in Oncology in 2007 and her Master of Arts in Healthcare Leadership in 2022. Jennifer began her career as an inpatient BMT pharmacist before taking on the role of Clinical Practice Leader where she supported pharmacist teams in pediatric and adult hematology/BMT and emergency medicine. Jennifer has also provided project leadership for the recent implementation of the provincial electronic health record in Alberta, Canada.

Jennifer is currently the Pharmacy Manager at the Foothills Medical Centre, a quaternary acute care hospital, where she is strongly committed to advancing the practice of clinical pharmacists within the multidisciplinary team. She is the current Chair of the ISOPP Equity, Diversity and Inclusion Task Force and a member of the ISOPP Research Committee.

Dr. Scott Nelson is a pharmacist and Associate Professor in the Department of Biomedical Informatics at Vanderbilt University Medical Center. Dr. Nelson is the Director of the Master of Science in Applied Clinical Informatics (MS-ACI) online program, and currently works in Medication Safety Informatics in HealthIT, with a focus on medication reconciliation, e-prescribing, artificial intelligence, and clinical decision support.

Pieter Ramaut graduated as a pharmacist in 2009 at KU Leuven and completed a ManaMa program in hospital pharmacy in 2012. From 2012 to 2019, he worked in various Flemish hospitals, engaging in a broad spectrum of activities ranging from clinical trials to cardiovascular implants. Since 2019, he has been serving as the head of the production department in the hospital pharmacy of the University Hospital of Ghent (UZ Gent), Belgium. In this role, he oversees pharmaceutical production processes and strives to optimize them using technological advancements.
Additionally, Pieter holds a position as Clinical Guest Professor at Universiteit Gent, where he teaches pharmaceutical technology to ManaMa hospital pharmacists.

A/Prof Alexander is a pharmacist-researcher dedicated to optimizing medication use, improving treatment efficacy, and minimizing toxicities for people living with cancer. As Deputy Director of Pharmacy (Quality and Research) at Peter MacCallum Cancer Centre and an Associate Professor at The University of Melbourne, A/Prof Alexander brings expertise in oncology pharmacy, thoracic cancers, clinical trials, population studies, and research focused on biomarker-driven therapies, pharmacogenomics, longitudinal registries, and biobanking.

Graduated in Pharmacy from the Federal University of Rio Grande do Sul (2012). Master's degree in Hepatology from the Federal University of Health Sciences of Porto Alegre (UFCSPA) (2016). She worked as a pharmacist in the Liver Transplant Group (Santa Casa de Misericórdia - Porto Alegre). Previously, she was a technical support fellow on the project for the Development and Implementation of a Hospital Drug Traceability System by the Observatory of Information and Communication Technologies in Health Systems and Services (OTICS) in partnership with the National Health Surveillance Agency (ANVISA), which was carried out at the Fêmina Hospital (GHC Group) in Porto Alegre/RS. She was a pharmacist at the Clinical Research Center, Moinhos de Vento Hospital for 4 years, where she also worked as a researcher at PROADI. Currently working in clinical research as a Project Manager.

Hadley is the Senior Pharmacist for Anticoagulation Stewardship (ACS) at Alfred Health. He completed a clinical pharmacy Fellowship in malignant hematology/bone marrow transplant in 2014 before commencing in the current role in developing Australia's inaugural ACS Program. Hadley has a keen interest in evaluating systems that support quality use of anticoagulants to improve patient outcomes. He is current co-chair of the burgeoning Thrombosis & Haemostasis Society of Australia and New Zealand (THANZ) Anticoagulation Stewardship Network and is also an avid fan of Australian rules football, chronically watching too many footy-related TV shows.

Dr. Hope Swanson is a Senior Clinical Pharmacy Specialist in pediatric hematology/oncology at St. Jude Children’s Research Hospital. As a credentialed provider, she cares for children with leukemia and lymphoma, precepts pharmacy residents and students, and contributes to clinical trials and research. Her research focuses on tailoring novel treatment approaches and understanding treatment-related toxicities in children with acute lymphoblastic leukemia. Dr. Swanson earned her Doctor of Pharmacy degree from the University of South Carolina and completed two years of post-graduate residency training, including a specialized residency in pediatric hematology/oncology at St. Jude.

Jesse Swen PharmD, PhD is a full professor of clinical pharmacy, in particular translational pharmacogenetics. He works as a clinical pharmacist-clinical pharmacologist at the Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center where he is the chair of the laboratory of the hospital pharmacy.  

The long-term central goal of his career is to improve the outcomes of drug treatment by gaining a better understanding of the genetic mechanisms that result in inter-individual variability in drug response.

Lee completed her pharmacy training at the University of Toronto, her residency at Sunnybrook Health Sciences Centre in Toronto and her PhD at the University of Amsterdam.  She is an Associate Senior Scientist, Research Institute; a Health Clinician Scientist, Department of Pharmacy, and a Clinical Pharmacist, Haematology/Oncology/Blood and Marrow Transplant/Cellular Therapy at SickKids, Canada and a Professor and Clinician Scientist at the Leslie Dan Faculty of Pharmacy, University of Toronto, Canada.  
Lee has leadership positions within the International Society of Paediatric Oncology (SIOP), the Multi-national Association of Supportive Care in Cancer, the Children’s Oncology Group and the Pediatric Oncology Group of Ontario.  She is the co-founder and co-director of the international Pediatric Oncology supportive care Guideline Network (iPOG Network).
Optimization of the supportive care of children who are receiving cancer treatment or undergoing hematopoietic cell transplant/cellular therapy is the focus of Lee’s research program.  Her work centers on facilitating communication about symptoms by children, evaluating interventions to control treatment-related toxicity and supportive care clinical practice guideline development and implementation.

PhD in Public Health, Specialist in Hospital Pharmacy in Logistics Operations Management. Works as a pharmacist in the Supply Division of the Brazilian National Cancer Institute (INCA), teaching postgraduate courses in Hospital Pharmacy, in INCA's Multiprofessional Residency Program in Oncology and in the Research Program in Collective Health and Cancer Control/INCA. President of the Brazilian Society of Oncology Pharmacists (SOBRAFO) for the 2025-2026 term. She has experience in Service Management, Supply Logistics and teaching in areas of Pharmaceutical Services and Public Procurement.

Dr. Brooke Bernhardt is the Chief Pharmaceutical Officer, Division Director of Pharmaceutical Services, and Associate Member in the Department of Pharmacy and Pharmaceutical Sciences. As a clinician scientist in molecular epidemiology, she aims to discover pharmacogenomic variations which influence treatment-related toxicities in pediatric cancer patients. As a healthcare leader, she strives to advance the practice of pharmacy globally, develop the next generation of pharmacists, reduce the impact of drug shortages, and optimize the pharmacotherapy of pediatric cancer treatment.

Amy has worked in Pharmacy since 2005 in a variety of sectors including Community, Hospital where she specialised in Manufacturing and production, Health in justice, General practice and Pharmaceutical industry, all of which led her to academia and her passion for developing and implementing pharmacy courses to support an inclusive and diverse workforce that aims to ensure the safety of medicines for patients and our society.

Having moved into an academic role in 2013, Amy now works at West Suffolk College, part of the Eastern Education group. Since 2019 Amy has led on the implementation of Science Manufacturing Technicians and Science Manufacturing Process operatives within technical services.

Alongside her employed role, Amy volunteers for and has held various positions within the Association of Pharmacy Technicians UK (APTUK) where she is currently Vice President. APTUK is the professional leadership body for Pharmacy Technicians within the UK. 

Sarah Glewis is a Senior Clinical Pharmacogenomics Pharmacist at Peter MacCallum Cancer Centre and a PhD Candidate at the University of Melbourne, Australia. Her current research efforts focus on clinical Pharmacogenomics (PGx) and Therapeutic Drug Monitoring (TDM) for the treatment and supportive care of cancer. She is the principal investigator for the first PGx multisite clinical trial in Australia (PACIFIC-PGx) and program manager for the follow-on trial with expanded PGx testing and TDM (PRECISION). She was awarded a research grant from ISOPP to support her PGx research work extending to regional areas in Australia and her work in PGx has been recognised in the Victorian HealthCare Award in Australia.

Glenn Myers is a pharmacist with a focus in outpatient medical oncology at the Dr. Sheldon H Rubin Oncology Clinic in Moncton, New Brunswick. Glenn completed a BSc (Pharmacy) at Dalhousie University in 2011 and subsequently went on to complete his hospital residency at the Saint John Regional Hospital in New Brunswick. Glenn has been practicing in ambulatory oncology for over 10 years and focuses on clinical assessment and management of chemotherapy, oral anti-cancer and immune related adverse effects in patients with cancer. Glenn maintains an active role as the chair of the sponsorship committee with the Canadian Association of Pharmacy in Oncology (CAPhO). Glenn’s other professional interests include teaching and mentoring various levels of pharmacy learners, providing practical education to healthcare professionals, working with retail pharmacies to improve oncology patient care in the community, and performing oncology pharmacy practice-based research to advance the scope of oncology pharmacy.

Dr. Christian Kollmannsberger, MD FRCPC

Dr. Kollmannsberger is a staff medical oncologist and Head, Department of Medical Oncology at BC Cancer, Vancouver Cancer Centre, as well as a Clinical Professor in the Division of Medical Oncology at the University of British Columbia. He has a full-time clinical practice focusing on genitourinary cancers and new drug development. He currently is the Chair of the BC Genitourinary Tumor Group as well as the GU Clinical Trials Unit at BC Cancer – Vancouver Center.

Dr. Kollmannsberger’s research is focused on genitourinary malignancies with a special interest in testicular and renal cell cancer. Nationally and internationally, he has contributed to numerous trials in the field of renal cell carcinoma and testicular cancer. He has authored or co-authored more than 280 publications in peer-reviewed journals including the Journal of Clinical Oncology, Annals of Oncology, Cancer Discovery, European Urology, and the New England Journal of Medicine.

He has repeatedly served as faculty for the Annual meeting of the American Society of Clinical Oncology (ASCO), the Annual Meeting of the European Society of Medical Oncology (ESMO), and as faculty and program chair for the ASCO Genitourinary Cancers Symposium.

Michelle Forman has been working in the outpatient oncology clinic at Burnaby Hospital since 1995, and prior to that had worked in various areas throughout the hospital. Her current role includes administering chemotherapy, patient teaching and management of disease symptoms and treatment side effects. Michelle is passionate about oncology nursing and feels that her knowledge and experience play an integral role in helping to provide for the physical and emotional patient care needs. Michelle has also enjoyed the opportunity to be involved in many projects aiming to enhance the cancer patients experience as well as educating fellow oncology nurses.

Systemic Therapy Process Coordinator at the Odette Cancer Centre Pharmacy at Sunnybrook Health Sciences Centre

Graduated Top of my class with a Pharmacy Technician Diploma from Compu-College in 2007. I later completed the Registered Pharmacy Technician (RPT) bridging program through Humber College and Selkirk College. I became licensed as a Registered Pharmacy Technician in Newfoundland and Labrador in 2017. I have worked for a short period of time with Central health in Grandfalls-Winsor NL, then since 2008 with Eastern Health in St. John’s NL. For the past 10 years my specialty area has been Sterile Hazardous Admixtures or Chemotherapy Preparation. I have been involved heavily in LEAN initiatives over the years, NAPRA policy implementation, and working on the design and implementation of a new Pharmacy Chemotherapy Suite at the Dr. H Bliss Murphy Center in St. John’s, NL. I have also recently begun a role of a Drug Access Navigator at the Dr. H Bliss Murphy Cancer Center, and work with Medical Oncology and Radiation Oncology. 

Scott Edwards is currently the Clinical Oncology Pharmacy Specialist at the Dr. H. Bliss Murphy Cancer Center in St. John’s, Newfoundland. He is also an assistant professor at the School of Pharmacy and the Discipline of Oncology, Faculty of Medicine, Memorial University of Newfoundland. He is active in clinical cancer research in the area of chemotherapy toxicities, supportive care and oral chemotherapy adherence. He graduated from Memorial University of Newfoundland with a B.Sc. (Neuroscience) in 1994 and a B.Sc (Pharmacy) in 1997. In 2005, he graduated with a Doctor of Pharmacy degree from the University of Washington. He completed a Master’s degree in Oncology from Newcastle University in 2015.

Glenn is a clinical resource pharmacist with a patient care focus in outpatient medical oncology at the Dr. Sheldon H Rubin Oncology Clinic in Moncton, New Brunswick. Glenn completed a BSc (Pharmacy) at Dalhousie University in 2011 and subsequently went on to complete his hospital residency at the Saint John Regional Hospital in New Brunswick. Glenn has been practicing in ambulatory oncology for over 12 years and focuses on clinical assessment and management of chemotherapy, oral anti-cancer, and immune related adverse effects in patients with cancer. Glenn also enjoys providing practical education to healthcare professionals in oncology and non-oncology settings.

Clinical Pharmacy Specialist
Lions Gate Hospital Oncology Clinic

Clinical Associate Professor
University of British Columbia

Joseph is the Education and Training Lead and Specialist Cancer Pharmacist at The Christie NHS Foundation Trust with a specialist clinical and research interest in colorectal cancer and care closer to home. He is also an independent prescriber within the colorectal cancer speciality. Joseph is an Honorary Clinical Lecturer at the University of Manchester (UoM) where he teaches on the Cancer programme for Undergraduates and Postgraduates. His background has vastly been in clinical practice and his patient facing role within the MDT has allowed him to initiate and progress applied health research projects in his area of practice to benefit patient care. His experience and accolades have allowed Joseph to be elected as Chair of the British Oncology Pharmacy Association (BOPA), elected as a member (and current Co-Chair) of the UK SACT Board, become a member of the UK Pharmacy Professional Leadership (UKPPL) Advisory Board and a Fellow of the Royal Pharmaceutical Society (RPS). Joseph is passionate about promoting excellence in pharmaceutical care of patients with cancer through education, research, and innovation.

Catherine Arnatt is an integrated clinical pharmacist at the Anchorage Native Primary Care Center with the Southcentral Foundation (SCF)/Alaska Native Medical Center (ANMC) and an officer with the US Public Health Service working within the Indian Health Service. CDR Arnatt has worked for the last 12 years with the Southcentral Foundation, a tribally owned health care organization serving nearly 70,000 Alaska Native and American Indian people in South Central Alaska. 

Catherine Arnatt received her Doctorate of Pharmacy from Virginia Commonwealth University’s Medical College of Virginia. She holds a Master of Science in Human Services Management, with an emphasis in Applied Behavior Analysis, and a Bachelor’s degree in Psychology with a minor in Sociology. Dr Arnatt is a Fellow of the Alaska Pharmacists Association and is Board Certified in Psychiatric Pharmacy. She acts as a Subject matter expert on Medication Assisted Treatment (MAT) and chronic pain management. She has held positions with behavioral health and special education programs serving children and adults with developmental disabilities and neuropsychiatric conditions, non-profit long-term care, outpatient clinics, and public-school settings. Cathy Arnatt enjoys travel and family time, advocating for underserved populations, and learning new things.

Adrienne Tveit is a Board-Certified Pharmacotherapy Specialist and currently works as an integrated clinical pharmacist at the Anchorage Native Primary Care Center with Southcentral foundation on the Alaska Native Medical Center campus in Anchorage, Alaska.  Alaska Native Medical Center is jointly owned and operated by Alaska Native Tribal Health Consortium and Southcentral Foundation, a tribally owned health care organization serving nearly 70,000 Alaska Native and American Indian people in Southcentral Alaska. Dr. Tveit has over 17 year’s experience at Southcentral Foundation.

Adrienne Tveit is Alaska Native of Tlingit Indian descent. Her family originated from Southeast Alaska, and she was born and raised in Kodiak, Alaska. Dr. Tveit attended the University of Alaska Fairbanks to obtain her undergraduate degree in Health Studies with an emphasis in Psychology, she went on to Washington State University and obtained her Doctor of Pharmacy degree before moving to Anchorage, Alaska to complete a PGY1 Pharmacy residency at the Alaska Native Medical Center. At Southcentral Foundation, Dr. Tveit has an interest in Infectious disease, she is on the Antimicrobial Stewardship Committee and precepts Pharmacy residents for an Infectious disease learning experience. 

Tom McFarlane received his Bachelor of Science in Pharmacy degree from the University of Toronto in 1996 and his Doctor of Pharmacy degree from Idaho State University in 2011. He has experience in the community pharmacy, hospital pharmacy, and academic pharmacy areas over the course of his career and is currently a Clinical Associate Professor and researcher at the University of Waterloo School of Pharmacy in Kitchener, Ontario where he teaches the oncology curriculum. He has been awarded over $500,000 in research grants from various sources, and has nearly 50 abstracts and articles published in the peer-reviewed literature.

Jurga McLean is an experienced hospital pharmacist and a Pre-Doctoral Research Fellow currently working at the Royal Marsden Hospital, UK. Her research area of interest lies within providing equitable cancer care to breast cancer patients who are receiving oral SACT. Jurga is an active member of BOPA research subcommittee and a Co-Chair of EDI subcommittee.  Jurga has recently published her “Scoping review identifying interventions that have been tested to optimise the experience of people from ethnic minority groups receiving systemic anti-cancer therapy (SACT)” and is continuing to work towards building her research proposal for further PhD studies. 

Abdelali Ouasrhir, is a pharmacist, researcher, and healthcare leader. He holds a PhD in Risk Management and an Executive MBA, bringing expertise in patient safety and healthcare innovation. He is the Head of the Clinical Research Department at the University Hospital of Oujda, Morocco, President of the Moroccan Association of Research and Training in Oncology Pharmacy, and Founder of a startup HealthBridgeTraining.com. He also coordinates the University Diploma in Oncology Pharmacy and has authored multiple publications, including the Practical Guide of Chemotherapy. Passionate about leadership and transformation in healthcare, he focuses on empowering professionals and integrating research into practice to drive innovation.

Dr. Goldspiel is the founding Editor of the Journal of Oncology Pharmacy Practice, the official publication of ISOPP. He received his B.S. in Pharmacy from the Arnold and Marie Schwartz College of Pharmacy in Brooklyn, New York and a Doctor of Pharmacy degree from the University of Texas Health Science Center at San Antonio. He completed a Specialized Residency in Oncology Pharmacy Practice at the Audie L. Murphy Veterans Hospital in San Antonio. Dr. Goldspiel is an active member of several pharmacy societies He is a fellow and a past-president ISOPP and HOPA.

Lee completed her pharmacy training at the University of Toronto, her residency at Sunnybrook Health Sciences Centre in Toronto and her PhD at the University of Amsterdam.  She is an Associate Senior Scientist, Research Institute; a Health Clinician Scientist, Department of Pharmacy, and a Clinical Pharmacist, Haematology/Oncology/Blood and Marrow Transplant/Cellular Therapy at SickKids, Canada and a Professor and Clinician Scientist at the Leslie Dan Faculty of Pharmacy, University of Toronto, Canada.  
Lee has leadership positions within the International Society of Paediatric Oncology (SIOP), the Multi-national Association of Supportive Care in Cancer, the Children’s Oncology Group and the Pediatric Oncology Group of Ontario.  She is the co-founder and co-director of the international Pediatric Oncology supportive care Guideline Network (iPOG Network).
Optimization of the supportive care of children who are receiving cancer treatment or undergoing hematopoietic cell transplant/cellular therapy is the focus of Lee’s research program.  Her work centers on facilitating communication about symptoms by children, evaluating interventions to control treatment-related toxicity and supportive care clinical practice guideline development and implementation.

Alan Birch is the Associate Director of Provider Solutions Oncology at Sentrex Health. He has 13 years' experience working in cancer care.  Alan is the former Drug Access Navigator at North York General Hospital in Toronto. He is the Founder of Drug Access Canada at drugaccess.ca. In 2021 Alan joined Sentrex Health where he currently manages the Haven Oncology Patient Support Program.

Amy has worked in Pharmacy since 2005 in a variety of sectors including Community, Hospital where she specialised in Manufacturing and production, Health in justice, General practice and Pharmaceutical industry, all of which led her to academia and her passion for developing and implementing pharmacy courses to support an inclusive and diverse workforce that aims to ensure the safety of medicines for patients and our society.

Having moved into an academic role in 2013, Amy now works at West Suffolk College, part of the Eastern Education group. Since 2019 Amy has led on the implementation of Science Manufacturing Technicians and Science Manufacturing Process operatives within technical services.

Alongside her employed role, Amy volunteers for and has held various positions within the Association of Pharmacy Technicians UK (APTUK) where she is currently Vice President. APTUK is the professional leadership body for Pharmacy Technicians within the UK. 

Katie Lacaria is a clinical pharmacy educator in leukemia and bone marrow transplantation at Vancouver General Hospital.  She completed a Hospital Pharmacy Residency Program from the University of British Columbia (UBC). She is a Clinical Instructor at UBC and a Clinical Consultant for Pharmacist’s Letter Canada.  Her areas of expertise and research interests include immunosuppressive pharmacotherapy, transplant-related infections, and drug allergies.

Melanie works at the Alberta College of Pharmacy as an Assessment Developer where she conducts program development and evaluation in the Continuing Competence Program, Structured Practical Training program, and Licensee Education Program. Melanie spent most of her career as an oncology pharmacist with a focus in breast cancer and has collaborated on several local, national, and international oncology pharmacy education initiatives. Her training in education and assessment includes completing Master of Education in Health Sciences Education in 2016 as well as several years of experience as an oncology pharmacy educator, residency coordinator, clinical practice leader, and instructor in the PharmD for Practicing Pharmacists program at the University of Alberta.

Jennifer graduated from the University of Alberta in 2000, obtaining her Board Certification in Oncology in 2007 and her Master of Arts in Healthcare Leadership in 2022. Jennifer began her career as an inpatient BMT pharmacist before taking on the role of Clinical Practice Leader where she supported pharmacist teams in pediatric and adult hematology/BMT and emergency medicine. Jennifer has also provided project leadership for the recent implementation of the provincial electronic health record in Alberta, Canada.

Jennifer is currently the Pharmacy Manager at the Foothills Medical Centre, a quaternary acute care hospital, where she is strongly committed to advancing the practice of clinical pharmacists within the multidisciplinary team. She is the current Chair of the ISOPP Equity, Diversity and Inclusion Task Force and a member of the ISOPP Research Committee.

Shellyza Sajwani is a pharmacist who works within areas of oncology, climate change and global health as they relate to the pharmacy profession. Shellyza received her MPharm from Aston University in the UK, her PharmD from the University of Toronto, her Climate Change and Health certification from Yale University and her Global Health Intensive Delivery Certification from Harvard University . She is currently an adjunct professor at the University of Ottawa, and the national co-chair of the Canadian Association of Pharmacy for the Environment (CAPhE - pronounced Caa-fee ). She has also worked for many years as an oncology pharmacist at the Ottawa Hospital, with ten years of experience in a combination of outpatient and inpatient oncology, and also co-chairs the Ottawa Hospital Pharmacy Environmental Committee. 

Shellyza co-chaired the International Pharmaceutical Federation (FIP) policy committee, which created and passed the first ever international pharmacy climate change policy in 2023 which went to the over 100 country membership representing four million pharmacy professionals. She also represented the University of Ottawa and the CAPhE at the United Nations COP29 conference in 2024 . Shellyza is currently the co-founder of Climaceutics Health Solutions which focuses on building on tools and certifications  for pharmacies to reduce their emissions and improve their climate resilience. 

Shellyza also has experience working as a previous co-president of Pharmacists Without Borders Canada ; and has received CAPhO Merit awards for her work as an oncology pharmacy consultant in Gulu, Uganda in 2017 and 2018, as well as her later work advocating for cancer patients with various patient advocacy organizations during her own chemotherapy treatment and during her remission. 

Data-driven healthcare improvement is at the heart of Shirley Yeung's work as Provincial Pharmacy Information Systems Coordinator at BC Cancer. She ensures safe and effective pharmacy services by overseeing the selection, implementation, and maintenance of pharmacy computer systems and managing drug inventory and contracting. With a background in pharmaceutical sciences (UBC, 2009), a hospital pharmacy residency, and a Master's in Public Health (Health Economics) from the London School of Hygiene and Tropical Medicine (2014), Shirley brings a strong analytical lens to her role. In her free time, she enjoys swimming.

Mollie Bishop is a Clinical Specialist Haemato-oncology Pharmacy Technician at the Royal Marsden Hospital.

Mollie completed her pre-registration pharmacy technician course at the Royal Marsden in 2014 and progressed up to a band 5 medicine management technician over the next year. In this role Mollie completed the ACPT and HEE medicines optimisation courses and worked on all inpatient wards on the Sutton site before settling in haematology. Mollie then left the trust taking on a new role at St Georges as a Clinical Transcribing Technician. This involved setting up a new service of pharmacy technicians transcribing discharge prescriptions. After this, Mollie returned to the Marsden to undertake a lead haemato-oncology pharmacy technician role. During her time in this role between 2020-2024, she started up new practices within the haematology team and found a love for this area of oncology. She completed her level 4 clinical diploma in June 2023. Lastly, her current role as Clinical Specialist Haemato-oncology Pharmacy Technician has meant that she has undertaken the BOPA SACT Verification passport and is verifying SACT within haemato-oncology. This role will also involve the roll out and education of this new skill across her pharmacy technician colleagues at the Royal Marsden.

Michelle Koberinski has worked in various community and hospital pharmacy settings in BC and Alberta since graduating from Vancouver Community College’s Pharmacy Technician Program in 1999. She currently works for Provincial Pharmacy at BC Cancer as the Oncology Certification Pharmacy Technician where she developed, implements, and maintains an Oncology Certification program for pharmacy staff in British Columbia that prepares and dispenses oncology medication. In 2010, Michelle received CAPhO’s Merit award for her work on the BCCA Pharmacy Practice Standards for Hazardous Drugs Manual. Michelle dedicates much of her time to improving aseptic compounding processes that involve hazardous drugs and developing guidelines for safe practice.

Laura is a Clinical Pharmacy Coordinator in Oncology and Hematology with Nova Scotia Health in Halifax. Laura obtained her BSc from Dalhousie University followed by a PhD in biochemistry from the University of Alberta. She then pursued pharmacy training and a Hospital Pharmacy Residency in Nova Scotia. She has worked with patients in both inpatient and ambulatory oncology settings and has developed and implemented a variety of pharmacist-led clinics. Laura is the CAPhO Research Chair and her research interests include pharmacist prescribing, optimizing patient education of oncology medications, CAR T-cell therapy, and management of toxicities associated with anticancer therapies.

Tiffany Chan is an experienced cancer pharmacist with over 16 years of expertise across four cancer centres. She serves as the Lead Pharmacist for Cancer Services at Great Western Hospital and Specialised Cancer Commissioning Pharmacist for NHS England (South West), leading innovations in chemotherapy service delivery and improving access to cancer treatments. She is Co-Chair of BOPA’s Research Subcommittee and Chair of ISOPP’s Engagement and Communications Committee, advocating for research, global collaboration, and professional development. Passionate about advancing both cancer pharmacists and pharmacy technicians, she actively supports career progression through the Education, Training, and Workforce Committees. Tiffany is a member of BOPA, ISOPP, ESMO, and EBMT.

Long time CAPhO and CAPhO Conference organizing and sponsorship committee member. Member of ISOPP, and founding member of local Toronto oncology pharmacists’ group, OPTRA. Oncology pharmacy education is so important to what we do every day; it helps to inspire new and seasoned practitioners to make a difference for their patients.

Dr. Tara Horrill is an Assistant Professor in the College of Nursing at the University of Manitoba, a Scientist at the Paul Albrechtsen Research Institute CancerCare Manitoba, and the founder and principal investigator for REACHE Lab. Her research takes a critical approach to investigating health inequities within the context of the cancer care system, with a particular focus on equitable access to cancer care and equity-oriented approaches to care. In her current role, Dr. Horrill is engaged in collaborative research and knowledge mobilization initiatives in partnership with interdisciplinary researchers, health care practitioners, health system leaders, and patients to generate evidence-informed improvements in care that will strategically address health inequities in the cancer care sector.

Pharmacist, Research Associate, PhD Candidate — Carl von Ossietzky Universität Oldenburg, School of Medicine and Health Sciences, Internal Medicine-Oncology

Lynne Nakashima received her BSc(Pharm) from the University of British Columbia, Canada and her PharmD from the University of North Carolina at Chapel Hill, USA. Lynne is a Fellow of both CAPhO and ISOPP and is currently the Chair of the ISOPP Grants and Awards Task Force as well as the CAPhO Fellow Task Force. She is currently the Senior Director, Provincial Pharmacy at BC Cancer in Canada where she is responsible for pharmacy professional practice leadership, provincial oncology medication management, support for the systemic therapy program and leadership for the Pharmacy Residency Program.

Cameron Roessner is a clinical pharmacist specializing in Bone Marrow Transplantation and Hematology at the Arthur J.E. Child Comprehensive Cancer Centre in Calgary, Alberta. Cameron is particularly interested in exploring innovative treatment options for hematological malignancies and developing strategies to improve their safety and tolerability. In addition, Cameron dedicates part of their practice to non-malignant hematology, caring for patients with rare blood disorders such as sickle cell disease and thalassemia. Cameron is passionate about advancing pharmacist involvement in the multidisciplinary care of hematology patients.

Netty has over 20 years’ experience as a specialist oncology pharmacist working in both government and private organisations within the UK. She is currently Principal Pharmacist – Operations, for Genesis Care UK.   Netty is currently President of The International Society of Oncology Pharmacy Practitioners (ISOPP) and co-chair of the UK SACT Board. Netty has previously held various leadership positions within the British Oncology Pharmacy Association (BOPA) and has independently led several National and International Projects.   Netty was announced a Fellow of the Royal Pharmaceutical Society in 2022 and a Fellow of BOPA in 2023. 

Netty is passionate about improving cancer care globally and improving safety for patients and staff through the use of digital media.  Netty also has a keen interest in education and training and uses her strengths to support all pharmacy staff in all sectors and countries to improve access to learning globally.

Nick is a Consultant Haematology Pharmacist at University Hospitals Birmingham NHS Foundation Trust and an Assistant Professor in the School of Pharmacy at the University of Birmingham. He is a Fellow of the British Oncology Pharmacy Association and the Royal Pharmaceutical Society of Great Britain and is the current Chair of the EBMT Pharmacist Committee. He is the chair of the ISOPP Research Committee, and his areas of research interest include medicines adherence, chronic myeloid leukaemia and antifungal stewardship.

Evelyn Handel, PharmD, BCPS, BCOP is Senior Director of Drugs & Biologics Programs at the National Comprehensive Cancer Network in Philadelphia, USA. In this role she collaborates with a multidisciplinary team and is responsible for strategic leadership and management of the NCCN Drugs & Biologics Compendium and the NCCN Chemotherapy Order Templates, which are derivative products of the NCCN Clinical Practice Guidelines in Oncology. Prior to joining NCCN, Evelyn was an oncology clinical pharmacy specialist in various direct patient care roles.

Evelyn is an active member of the International Society of Oncology Pharmacy Practitioners (ISOPP) as well as the Hematology/Oncology Pharmacy Association (HOPA). She has served in multiple volunteer leadership positions including Chair of the HOPA Patient Education Committee, as well as on the ISOPP Secretariat in various roles since 2015 including her current term as immediate Past President and Governance Committee Chair.

Irene holds a master’s degree in clinical pharmacy with specialization in oncology pharmacy from the University of Nairobi and has over 20 years’ experience as a specialist pharmacist, serving in national, regional and international expert advisory and technical working groups. She is an active member of several professional associations and has served on the ISOPP Board since 2020. Irene is an adjunct faculty at the University of Nairobi and Kabarak University, providing research and clinical practice supervision to undergraduate and postgraduate pharmacy students.